As a part of a study testing out a new type of implanted brain-computer interface (BCI), three rhesus monkeys controlled ...
Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today announced that the U.S. Food and Drug ...
As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...
A unit of Goldman Sachs Asset Management invested $50 million in BLP Digital, a Swiss artificial intelligence company that ...
These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...
Seeed Studio reBot Arm B601-DM is a fully open-source 6-axis robotic arm (plus a parallel gripper) designed to lower the ...
Engineers interested in creating artificial cells to deliver drugs to unhealthy parts of the body face a key challenge: for a ...
Guest post about Linux CPU power management for embedded systems, specifically covering cpuidle in depth, including drivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results